Heart Failure Clinical Trial

CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study

Summary

This is a study to determine if two ultrasound measures (Corrected Flow Time and B-Lines) can predict patients at higher risk of readmission within 30 days of hospital discharge for decompensated heart failure.

View Full Description

Full Description

Heart failure (HF) resulting in congestion is the leading cause for admission in persons ≥65 years of age and 20-25% of such patients are readmitted within 30 days of discharge. Efforts to treat HF are difficult without a simple method to detect early signs of congestion to direct therapy. Ultrasound can detect evidence of congestion by increased cardiac filling pressures two weeks prior to other markers of congestion such as weight gain or patient symptoms. Corrected flow time (FTc) measured by ultrasound, is an easy to perform vascular measure and correlates with cardiac filling pressures. Despite the relationship between FTc and filling pressures, this measure has never been studied in HF. The primary aim is to determine if FTc can predict patients at risk of readmission within 30 days. As a secondary aim, the investigators plan to validate a small study of patients reporting the ability of pulmonary ultrasound to predict readmissions. This study demonstrated pulmonary ultrasound was 100% sensitive and 68% specific for predicting readmission at 3 months, however this investigation was small and validation is needed. It is expected ultrasound will be able to accurately and safely predict patients who will be readmitted within 30 days of discharge. This proposal is aimed at identifying a noninvasive measure to better assess congestion from HF and predict readmissions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

English Speaking
Being admitted for heart failure with expected hospital stay of 72 hours

Exclusion Criteria:

Unable to provide consent

Study is for people with:

Heart Failure

Estimated Enrollment:

187

Study ID:

NCT02996032

Recruitment Status:

Completed

Sponsor:

Boston Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Boston University
Boston Massachusetts, 02119, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

187

Study ID:

NCT02996032

Recruitment Status:

Completed

Sponsor:


Boston Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider